Bio-behavioral Consequences of Appearance and Performance Enhancing Drug Use
Bio-behavioral Consequences of Appearance and Performance Enhancing Drug Use
批准号:
8081856
负责人:
THOMAS B HILDEBRANDT
金额:
$17.7万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2013-05-31
关键词:
AdultAgeAggressive behaviorAminobutyric AcidsAnabolic steroidsAppearanceAreaArgipressinAthleticBehaviorBehavioralBiologicalCharacteristicsClinicalClinical ResearchDataDependenceDevelopmentDiseaseDrug usageDrug userEatingEducationEducational BackgroundEndocrineEnvironmentEthical IssuesEthicsExerciseFatty acid glycerol estersFunctional disorderFundingGoalsGrowthHormonalHormonesImpulsivityIndividualK-Series Research Career ProgramsKnowledgeLearningLegalLicensingLinkLongitudinal StudiesMediatingMediator of activation proteinMedicalMetabolicMethodologyMissionModelingMoodsMuscleNandroloneNeuroendocrinologyNeurosecretory SystemsNeurotransmittersPatternPerformancePersonalityPharmaceutical PreparationsPoliciesPreventive InterventionPsychiatryPsychologistPublic HealthRecording of previous eventsRegulationResearchResearch PersonnelResearch Project GrantsResourcesSamplingScienceScientistSerotoninSubstance abuse problemSystemTestosteroneTimeTrainingTranslational ResearchWeightWorkadverse outcomebasebehavior changecareerclinically significantdata modelingdesigndisturbance in affectexperiencefallsimprovedinterestmalemedical schoolspatient orientedprofessorprogramsresponseself esteemskillssocialtheories
中文摘要
描述(由申请人提供):建议的K23患者导向职业发展奖旨在为PI提供必要的培训,以研究使用外貌和表现增强药物(APED)在生物行为后果方面的个体差异。候选人:PI是一名助理教授和执业临床心理学家,目前在西奈山医学院(MSSM‘s)饮食和体重障碍项目工作。他计划使用K23成为R01资助的研究人员,与基础科学家和翻译科学家密切合作,解决APED使用带来的临床、伦理和科学挑战。为了实现这些职业目标,他将使用K23获得必要的知识、技能和能力,以研究APED使用者的内分泌/神经内分泌功能和攻击性/冲动之间的关系。他的具体培训目标是(A)学习研究APED使用的病理和非病理形式之间的区别的理论、方法和临床方法,(B)发展通过翻译研究获得的理论和方法的实用知识,以研究激素与行为的关系,(C)获得将激素失调与精神疾病联系起来的理论和方法方面的专业知识,(D)更好地了解与研究药物滥用相关的医学、法律和伦理问题,以及(E)获得生物数据的纵向数据建模和统计分析方面的专业知识。环境:PI提出的培训计划和职业目标与MSSM精神病学系整合翻译和临床研究的使命声明是一致的,特别是在神经内分泌学领域。希尔德布兰特博士拥有丰富的专业知识和可用的资源,包括研究内分泌和神经内分泌功能所需的实验室。研究:使用类人猿最可靠的精神后果是增加冲动攻击性,尽管已经观察到一系列精神障碍。这项有监督的研究项目将对60名成年雄性类人猿使用者在不同时间(周期内和周期外)的激素和精神调节失调(攻击性和冲动性)程度进行纵向研究,并与20名年龄、锻炼和教育相匹配的对照组进行比较。分段潜在增长曲线模型将用于研究周期内和周期外的变化,并将探索以下变化的预测因素:APED特征(数量、持续时间和模式)、年龄、精神病史、个性和APED使用史)。相关性:拟议研究的结果将有助于确定导致APED使用的精神后果的内分泌功能障碍,以及预测这些精神后果的使用者特征。这项研究的意义在于为与这一日益增长的公共卫生问题相关的预防、干预和基于政策的决策提供信息。
英文摘要
DESCRIPTION (provided by applicant): The proposed K23 Patient-Oriented Career Development Award is designed to provide the PI with the training necessary to study the individual variability in bio-behavioral consequences of appearance and performance enhancing drug (APED) use. Candidate: The PI is an Assistant Professor and licensed clinical Psychologist currently working at the Mount Sinai School of Medicine's (MSSM's) Eating and Weight Disorders Program. He plans to use the K23 to become an R01 funded researcher that works closely with basic and translational scientists on the clinical, ethical, and scientific challenges presented by APED use. In order to obtain these career goals, he will use the K23 to acquire knowledge, skills, and abilities necessary to the study the relationship between endocrine/neuroendocrine function and aggression/impulsivity among APED users. His specific training objectives are to (a) learn the theoretical, methodological, and clinical approaches to studying the distinction between pathological and non-pathological forms of APED use, (b) develop a working knowledge of the theory and methodology available through translational research to study hormone-behavior relationships, (c) acquire expertise in the theory and methodology linking hormone dysregulation to psychiatric illness, (d) acquire greater understanding of the medical, legal, and ethical issues associated with studying substance abuse, and (e) obtain expertise in longitudinal data modeling and statistical analysis of biological data. Environment: The Pi's proposed training plan and career goals are consistent with the MSSM Department of Psychiatry's mission statement to integrate translational and clinical research, particularly in the area of neuroendocrinology. Dr. Hildebrandt has available to him a wealth of expertise and resources available including the lab facilitates necessary to study both endocrine and neuroendocrine functioning. Research: The most reliable psychiatric consequence to APED use is increased impulsive aggression although a range of psychiatric disturbances have been observed. The supervised research project will be a longitudinal study of the degree of both hormone and psychiatric dysregulation (aggression and impulsivity) in 60 adult male APED users across time (on-cycle and off-cycle) compared to 20 age, exercise, and education matched controls. Piecewise latent growth curve modeling will be used to investigate changes on-cycle and off-cycle changes and the following predictors of change will be explored: APED characteristics (amount, duration, and pattern), Age, Psychiatric History, Personality, & History of APED use). Relevance: Findings from the proposed study will help identify both the endocrine dysfunction responsible for the psychiatric consequences to APED use and the user characteristics predictive of these psychiatric consequences. Implications of this research are to inform prevention, intervention, and policy based decisions related to this growing public health concern.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Confirmatory Efficacy Study of Interoceptive Exposure for Adolescents with Low Weight Eating Disorders
-
批准号:10571565
-
项目类别:
-
资助金额:$78.62万
-
财政年份:2023
-
负责人:THOMAS B HILDEBRANDT
-
依托单位:
General Brain Arousal and Risk for Eating Disorder
-
批准号:10365378
-
项目类别:
-
资助金额:$43.41万
-
财政年份:2021
-
负责人:THOMAS B HILDEBRANDT
-
依托单位:
General Brain Arousal and Risk for Eating Disorder
-
批准号:10656518
-
项目类别:
-
资助金额:$40.12万
-
财政年份:2021
-
负责人:THOMAS B HILDEBRANDT
-
依托单位:
Noom Coach for Bariatric Surgery
-
批准号:9464753
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2017
-
负责人:THOMAS B HILDEBRANDT
-
依托单位:
Reward Systems and Food Avoidance in Adolescents with Low Weight Eating Disorders
-
批准号:9334942
-
项目类别:
-
资助金额:$59.42万
-
财政年份:2016
-
负责人:THOMAS B HILDEBRANDT
-
依托单位:
Reward Systems and Food Avoidance in Adolescents with Low Weight Eating Disorders
-
批准号:10222953
-
项目类别:
-
资助金额:$22.09万
-
财政年份:2016
-
负责人:THOMAS B HILDEBRANDT
-
依托单位:
Innovative Use of the Noom Monitor Mobile Application for CBT-GSH in Binge Eaters
-
批准号:8521678
-
项目类别:
-
资助金额:$34.37万
-
财政年份:2013
-
负责人:THOMAS B HILDEBRANDT
-
依托单位:
Innovative Use of the Noom Monitor Mobile Application for CBT-GSH in Binge Eaters
-
批准号:8665495
-
项目类别:
-
资助金额:$33.03万
-
财政年份:2013
-
负责人:THOMAS B HILDEBRANDT
-
依托单位:
Bio-behavioral Consequences of Appearance and Performance Enhancing Drug Use
-
批准号:7530230
-
项目类别:
-
资助金额:$17.67万
-
财政年份:2008
-
负责人:THOMAS B HILDEBRANDT
-
依托单位:
Bio-behavioral Consequences of Appearance and Performance Enhancing Drug Use
-
批准号:8269936
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2008
-
负责人:THOMAS B HILDEBRANDT
-
依托单位:
Bio-behavioral Consequences of Appearance and Performance Enhancing Drug Use
-
批准号:7660530
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2008
-
负责人:THOMAS B HILDEBRANDT
-
依托单位:
Bio-behavioral Consequences of Appearance and Performance Enhancing Drug Use
-
批准号:7848976
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2008
-
负责人:THOMAS B HILDEBRANDT
-
依托单位:
Assessment of Appearance and Performance Enhancing Drug Use
-
批准号:7501901
-
项目类别:
-
资助金额:$8.93万
-
财政年份:2007
-
负责人:THOMAS B HILDEBRANDT
-
依托单位:
Assessment of Appearance and Performance Enhancing Drug Use
-
批准号:7186844
-
项目类别:
-
资助金额:$9.06万
-
财政年份:2007
-
负责人:THOMAS B HILDEBRANDT
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: